New Delhi: Serum Institute and Bharat Biotech on Tuesday issued a joint statement pledging to provide their Covid-19 vaccines to India and globally.
"Adar Poonawala and Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the Covid-19 vaccines for India and globally," the statement read.
It went on to highlight the importance of vaccines as a global public health good that have "the power to save lives and accelerate the return to economic normalcy at the earliest."
Bharat Biotech's chairman Krishna Ella had earlier on Monday retaliated to Serum CEO Adar Poonawalla's statement of vaccines except Pfizer, Moderna and Oxford-AstraZeneca being "safe like water".
“We do 200% honest clinical trials and yet we receive backlash. If I am wrong, tell me. Some companies have branded me (our vaccine) like 'water'. I want to deny that. We are scientists," Ella said.
Poonawalla had earlier said that Covishield’s emergency use approval was granted on the condition that the company does not export the shots to ensure enough stockpile for India.
Covishield and Bharat Biotech’s Covaxin have both got emergency use approval in India as of this week.
"Adar Poonawala and Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the Covid-19 vaccines for India and globally," the statement read.
It went on to highlight the importance of vaccines as a global public health good that have "the power to save lives and accelerate the return to economic normalcy at the earliest."
Bharat Biotech's chairman Krishna Ella had earlier on Monday retaliated to Serum CEO Adar Poonawalla's statement of vaccines except Pfizer, Moderna and Oxford-AstraZeneca being "safe like water".
“We do 200% honest clinical trials and yet we receive backlash. If I am wrong, tell me. Some companies have branded me (our vaccine) like 'water'. I want to deny that. We are scientists," Ella said.
I would like to clarify two matters; as there is confusion in the public domain, exports of vaccines are permitted… https://t.co/W2uygvHceg
— Adar Poonawalla (@adarpoonawalla) 1609831993000Poonawalla had earlier said that Covishield’s emergency use approval was granted on the condition that the company does not export the shots to ensure enough stockpile for India.
Covishield and Bharat Biotech’s Covaxin have both got emergency use approval in India as of this week.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
13 Comments on this Story
 | Vitthal P55 minutes ago Yesterday interview of Bharat Biotech CEO, he did not gave direct answers but gave evasive replies. He was busy making big claims without any valid data. It will be foolish to even take their vaccine at this stage. |
| Jayaraman Iyer1 hour ago Both companies have achieved their marketing and PR excersise. |
 | Natarajan Rajamani1 hour ago I fully endorse Mr Kulkarniâ s views on Adoor. He has to mature not to be arrogant.... |